Discovery and Validation of a Novel Class of Necroptosis Inhibitors Targeting RIPK1.
Saved in:
| Title: | Discovery and Validation of a Novel Class of Necroptosis Inhibitors Targeting RIPK1. |
|---|---|
| Authors: | Soday L; Department of Chemistry, Molecular Sciences Research Hub, Imperial College London, London W12 0BZ, U.K., Seripracharat C; Department of Chemistry, Molecular Sciences Research Hub, Imperial College London, London W12 0BZ, U.K., Gray JL; Department of Chemistry, Molecular Sciences Research Hub, Imperial College London, London W12 0BZ, U.K., Luz AFS; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon 1649-004, Portugal., Howard RT; Department of Chemistry, Molecular Sciences Research Hub, Imperial College London, London W12 0BZ, U.K., Singh R; Department of Chemistry, Molecular Sciences Research Hub, Imperial College London, London W12 0BZ, U.K., Burden TJ; Department of Chemistry, Molecular Sciences Research Hub, Imperial College London, London W12 0BZ, U.K., Bernardini E; Department of Chemistry, Molecular Sciences Research Hub, Imperial College London, London W12 0BZ, U.K., Mateus-Pinheiro M; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon 1649-004, Portugal., Petersen J; Discovery Sciences, R&D Gothenburg, AstraZeneca, Pepparedsleden 1, SE-431 83 Mölndal, Sweden., Gunnarsson A; Discovery Sciences, R&D Gothenburg, AstraZeneca, Pepparedsleden 1, SE-431 83 Mölndal, Sweden., Gunnarsson J; Discovery Sciences, R&D Gothenburg, AstraZeneca, Pepparedsleden 1, SE-431 83 Mölndal, Sweden., Aagaard A; Discovery Sciences, R&D Gothenburg, AstraZeneca, Pepparedsleden 1, SE-431 83 Mölndal, Sweden., Sjögren T; Discovery Sciences, R&D Gothenburg, AstraZeneca, Pepparedsleden 1, SE-431 83 Mölndal, Sweden., Maslen S; The Francis Crick Institute, London NW1 1AT, U.K., Bartlett EJ; Department of Chemistry, Molecular Sciences Research Hub, Imperial College London, London W12 0BZ, U.K., Iles AF; Department of Chemistry, Molecular Sciences Research Hub, Imperial College London, London W12 0BZ, U.K., Smith DM; Hit Discovery, Discovery Sciences, R&D, AstraZeneca, Cambridge CB2 0AA, U.K., Scott JS; Hit Discovery, Discovery Sciences, R&D, AstraZeneca, Cambridge CB2 0AA, U.K., Skehel M; The Francis Crick Institute, London NW1 1AT, U.K., Davis AM; Hit Discovery, Discovery Sciences, R&D, AstraZeneca, Cambridge CB2 0AA, U.K., Ressurreição AS; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon 1649-004, Portugal., Moreira R; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon 1649-004, Portugal., Rodrigues CMP; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon 1649-004, Portugal., Shenoy AR; Department of Infectious Diseases, Imperial College London, Flowers Building, South Kensington Campus, London SW7 2AZ, U.K., Tate EW; Department of Chemistry, Molecular Sciences Research Hub, Imperial College London, London W12 0BZ, U.K.; The Francis Crick Institute, London NW1 1AT, U.K. |
| Source: | ACS chemical biology [ACS Chem Biol] 2025 Jul 18; Vol. 20 (7), pp. 1527-1543. Date of Electronic Publication: 2025 Jun 20. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Chemical Society Country of Publication: United States NLM ID: 101282906 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1554-8937 (Electronic) Linking ISSN: 15548929 NLM ISO Abbreviation: ACS Chem Biol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40539767 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Discovery and Validation of a Novel Class of Necroptosis Inhibitors Targeting RIPK1. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Soday+L%22">Soday L</searchLink>; Department of Chemistry, Molecular Sciences Research Hub, Imperial College London, London W12 0BZ, U.K.<br /><searchLink fieldCode="AU" term="%22Seripracharat+C%22">Seripracharat C</searchLink>; Department of Chemistry, Molecular Sciences Research Hub, Imperial College London, London W12 0BZ, U.K.<br /><searchLink fieldCode="AU" term="%22Gray+JL%22">Gray JL</searchLink>; Department of Chemistry, Molecular Sciences Research Hub, Imperial College London, London W12 0BZ, U.K.<br /><searchLink fieldCode="AU" term="%22Luz+AFS%22">Luz AFS</searchLink>; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon 1649-004, Portugal.<br /><searchLink fieldCode="AU" term="%22Howard+RT%22">Howard RT</searchLink>; Department of Chemistry, Molecular Sciences Research Hub, Imperial College London, London W12 0BZ, U.K.<br /><searchLink fieldCode="AU" term="%22Singh+R%22">Singh R</searchLink>; Department of Chemistry, Molecular Sciences Research Hub, Imperial College London, London W12 0BZ, U.K.<br /><searchLink fieldCode="AU" term="%22Burden+TJ%22">Burden TJ</searchLink>; Department of Chemistry, Molecular Sciences Research Hub, Imperial College London, London W12 0BZ, U.K.<br /><searchLink fieldCode="AU" term="%22Bernardini+E%22">Bernardini E</searchLink>; Department of Chemistry, Molecular Sciences Research Hub, Imperial College London, London W12 0BZ, U.K.<br /><searchLink fieldCode="AU" term="%22Mateus-Pinheiro+M%22">Mateus-Pinheiro M</searchLink>; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon 1649-004, Portugal.<br /><searchLink fieldCode="AU" term="%22Petersen+J%22">Petersen J</searchLink>; Discovery Sciences, R&D Gothenburg, AstraZeneca, Pepparedsleden 1, SE-431 83 Mölndal, Sweden.<br /><searchLink fieldCode="AU" term="%22Gunnarsson+A%22">Gunnarsson A</searchLink>; Discovery Sciences, R&D Gothenburg, AstraZeneca, Pepparedsleden 1, SE-431 83 Mölndal, Sweden.<br /><searchLink fieldCode="AU" term="%22Gunnarsson+J%22">Gunnarsson J</searchLink>; Discovery Sciences, R&D Gothenburg, AstraZeneca, Pepparedsleden 1, SE-431 83 Mölndal, Sweden.<br /><searchLink fieldCode="AU" term="%22Aagaard+A%22">Aagaard A</searchLink>; Discovery Sciences, R&D Gothenburg, AstraZeneca, Pepparedsleden 1, SE-431 83 Mölndal, Sweden.<br /><searchLink fieldCode="AU" term="%22Sjögren+T%22">Sjögren T</searchLink>; Discovery Sciences, R&D Gothenburg, AstraZeneca, Pepparedsleden 1, SE-431 83 Mölndal, Sweden.<br /><searchLink fieldCode="AU" term="%22Maslen+S%22">Maslen S</searchLink>; The Francis Crick Institute, London NW1 1AT, U.K.<br /><searchLink fieldCode="AU" term="%22Bartlett+EJ%22">Bartlett EJ</searchLink>; Department of Chemistry, Molecular Sciences Research Hub, Imperial College London, London W12 0BZ, U.K.<br /><searchLink fieldCode="AU" term="%22Iles+AF%22">Iles AF</searchLink>; Department of Chemistry, Molecular Sciences Research Hub, Imperial College London, London W12 0BZ, U.K.<br /><searchLink fieldCode="AU" term="%22Smith+DM%22">Smith DM</searchLink>; Hit Discovery, Discovery Sciences, R&D, AstraZeneca, Cambridge CB2 0AA, U.K.<br /><searchLink fieldCode="AU" term="%22Scott+JS%22">Scott JS</searchLink>; Hit Discovery, Discovery Sciences, R&D, AstraZeneca, Cambridge CB2 0AA, U.K.<br /><searchLink fieldCode="AU" term="%22Skehel+M%22">Skehel M</searchLink>; The Francis Crick Institute, London NW1 1AT, U.K.<br /><searchLink fieldCode="AU" term="%22Davis+AM%22">Davis AM</searchLink>; Hit Discovery, Discovery Sciences, R&D, AstraZeneca, Cambridge CB2 0AA, U.K.<br /><searchLink fieldCode="AU" term="%22Ressurreição+AS%22">Ressurreição AS</searchLink>; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon 1649-004, Portugal.<br /><searchLink fieldCode="AU" term="%22Moreira+R%22">Moreira R</searchLink>; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon 1649-004, Portugal.<br /><searchLink fieldCode="AU" term="%22Rodrigues+CMP%22">Rodrigues CMP</searchLink>; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon 1649-004, Portugal.<br /><searchLink fieldCode="AU" term="%22Shenoy+AR%22">Shenoy AR</searchLink>; Department of Infectious Diseases, Imperial College London, Flowers Building, South Kensington Campus, London SW7 2AZ, U.K.<br /><searchLink fieldCode="AU" term="%22Tate+EW%22">Tate EW</searchLink>; Department of Chemistry, Molecular Sciences Research Hub, Imperial College London, London W12 0BZ, U.K.; The Francis Crick Institute, London NW1 1AT, U.K. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101282906%22">ACS chemical biology</searchLink> [ACS Chem Biol] 2025 Jul 18; Vol. 20 (7), pp. 1527-1543. <i>Date of Electronic Publication: </i>2025 Jun 20. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Chemical+Society%22">American Chemical Society </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101282906 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1554-8937 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215548929%22">15548929 </searchLink><i>NLM ISO Abbreviation: </i>ACS Chem Biol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40539767 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1021/acschembio.5c00112 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1527 Titles: – TitleFull: Discovery and Validation of a Novel Class of Necroptosis Inhibitors Targeting RIPK1. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Soday L – PersonEntity: Name: NameFull: Seripracharat C – PersonEntity: Name: NameFull: Gray JL – PersonEntity: Name: NameFull: Luz AFS – PersonEntity: Name: NameFull: Howard RT – PersonEntity: Name: NameFull: Singh R – PersonEntity: Name: NameFull: Burden TJ – PersonEntity: Name: NameFull: Bernardini E – PersonEntity: Name: NameFull: Mateus-Pinheiro M – PersonEntity: Name: NameFull: Petersen J – PersonEntity: Name: NameFull: Gunnarsson A – PersonEntity: Name: NameFull: Gunnarsson J – PersonEntity: Name: NameFull: Aagaard A – PersonEntity: Name: NameFull: Sjögren T – PersonEntity: Name: NameFull: Maslen S – PersonEntity: Name: NameFull: Bartlett EJ – PersonEntity: Name: NameFull: Iles AF – PersonEntity: Name: NameFull: Smith DM – PersonEntity: Name: NameFull: Scott JS – PersonEntity: Name: NameFull: Skehel M – PersonEntity: Name: NameFull: Davis AM – PersonEntity: Name: NameFull: Ressurreição AS – PersonEntity: Name: NameFull: Moreira R – PersonEntity: Name: NameFull: Rodrigues CMP – PersonEntity: Name: NameFull: Shenoy AR – PersonEntity: Name: NameFull: Tate EW IsPartOfRelationships: – BibEntity: Dates: – D: 18 M: 07 Text: 2025 Jul 18 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1554-8937 Numbering: – Type: volume Value: 20 – Type: issue Value: 7 Titles: – TitleFull: ACS chemical biology Type: main |
| ResultId | 1 |